KR100608176B1 - 프로스타글란딘 및 벤질 알코올을 포함하는 용액제 - Google Patents

프로스타글란딘 및 벤질 알코올을 포함하는 용액제 Download PDF

Info

Publication number
KR100608176B1
KR100608176B1 KR1020007014321A KR20007014321A KR100608176B1 KR 100608176 B1 KR100608176 B1 KR 100608176B1 KR 1020007014321 A KR1020007014321 A KR 1020007014321A KR 20007014321 A KR20007014321 A KR 20007014321A KR 100608176 B1 KR100608176 B1 KR 100608176B1
Authority
KR
South Korea
Prior art keywords
benzyl alcohol
solution
water
delete delete
dinoprost tromethamine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
KR1020007014321A
Other languages
English (en)
Korean (ko)
Other versions
KR20010052944A (ko
Inventor
로버트 지. 리
Original Assignee
파마시아 앤드 업존 캄파니 엘엘씨
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 파마시아 앤드 업존 캄파니 엘엘씨 filed Critical 파마시아 앤드 업존 캄파니 엘엘씨
Publication of KR20010052944A publication Critical patent/KR20010052944A/ko
Application granted granted Critical
Publication of KR100608176B1 publication Critical patent/KR100608176B1/ko
Assigned to 조에티스 피앤드유 엘엘씨 reassignment 조에티스 피앤드유 엘엘씨 권리의 전부이전등록 Assignors: 파마시아 앤드 업존 캄파니 엘엘씨
Assigned to 조에티스 서비시즈 엘엘씨 reassignment 조에티스 서비시즈 엘엘씨 권리의 전부이전등록 Assignors: 조에티스 피앤드유 엘엘씨
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
    • A61K31/5575—Eicosanoids, e.g. leukotrienes or prostaglandins having a cyclopentane, e.g. prostaglandin E2, prostaglandin F2-alpha
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
KR1020007014321A 1998-06-17 1999-06-08 프로스타글란딘 및 벤질 알코올을 포함하는 용액제 Expired - Lifetime KR100608176B1 (ko)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US09/094,985 US6187818B1 (en) 1998-06-17 1998-06-17 Prostaglandins formulation and process
US09/094,985 1998-06-17

Publications (2)

Publication Number Publication Date
KR20010052944A KR20010052944A (ko) 2001-06-25
KR100608176B1 true KR100608176B1 (ko) 2006-08-04

Family

ID=22248341

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020007014321A Expired - Lifetime KR100608176B1 (ko) 1998-06-17 1999-06-08 프로스타글란딘 및 벤질 알코올을 포함하는 용액제

Country Status (14)

Country Link
US (1) US6187818B1 (https=)
EP (1) EP1085907B1 (https=)
JP (1) JP4472175B2 (https=)
KR (1) KR100608176B1 (https=)
CN (1) CN1188170C (https=)
AT (1) ATE263576T1 (https=)
AU (1) AU752047B2 (https=)
CA (1) CA2331284C (https=)
DE (1) DE69916266T2 (https=)
DK (1) DK1085907T3 (https=)
ES (1) ES2219036T3 (https=)
NZ (1) NZ508947A (https=)
PT (1) PT1085907E (https=)
WO (1) WO1999065527A1 (https=)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE281432T1 (de) 1999-03-05 2004-11-15 Univ Duke C-16 ungesätigte fp-selektive prostaglandin analoge
US6894175B1 (en) 1999-08-04 2005-05-17 The Procter & Gamble Company 2-Decarboxy-2-phosphinico prostaglandin derivatives and methods for their preparation and use
US20020172693A1 (en) 2000-03-31 2002-11-21 Delong Michell Anthony Compositions and methods for treating hair loss using non-naturally occurring prostaglandins
US20020037914A1 (en) 2000-03-31 2002-03-28 Delong Mitchell Anthony Compositions and methods for treating hair loss using C16-C20 aromatic tetrahydro prostaglandins
US20020013294A1 (en) 2000-03-31 2002-01-31 Delong Mitchell Anthony Cosmetic and pharmaceutical compositions and methods using 2-decarboxy-2-phosphinico derivatives
CN108078998B (zh) * 2017-11-23 2018-09-21 宁波三生生物科技有限公司 一种氨基丁三醇前列腺素F2α注射液及其制备方法

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3903297A (en) * 1973-11-01 1975-09-02 Upjohn Co Method of treatment and prophylaxis of gastric hypersecretion and gastric and duodenal ulcers using prostaglandin analogs

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3885041A (en) * 1970-12-28 1975-05-20 Searle & Co Antiinflammatory use of prostaglandins
US3917864A (en) 1973-02-12 1975-11-04 Sultanali M M Karim Use of prostaglandins E and F for induction of labor
EP0268066A3 (en) 1986-10-17 1990-07-11 Syntex (U.S.A.) Inc. Fertility control and uterine therapy in dogs with luteinizing hormone releasing hormone antagonists
AR002194A1 (es) 1997-03-17 1998-01-07 Sanchez Reynaldo Alemany Instrumento computarizado para el analisis del movimiento.

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3903297A (en) * 1973-11-01 1975-09-02 Upjohn Co Method of treatment and prophylaxis of gastric hypersecretion and gastric and duodenal ulcers using prostaglandin analogs

Also Published As

Publication number Publication date
CA2331284C (en) 2009-09-22
DE69916266T2 (de) 2005-03-10
ES2219036T3 (es) 2004-11-16
AU5079699A (en) 2000-01-05
US6187818B1 (en) 2001-02-13
JP2002518348A (ja) 2002-06-25
EP1085907A1 (en) 2001-03-28
DK1085907T3 (da) 2004-06-21
WO1999065527A1 (en) 1999-12-23
NZ508947A (en) 2003-05-30
CN1301178A (zh) 2001-06-27
CN1188170C (zh) 2005-02-09
HK1036413A1 (en) 2002-01-04
JP4472175B2 (ja) 2010-06-02
KR20010052944A (ko) 2001-06-25
ATE263576T1 (de) 2004-04-15
CA2331284A1 (en) 1999-12-23
DE69916266D1 (de) 2004-05-13
AU752047B2 (en) 2002-09-05
EP1085907B1 (en) 2004-04-07
PT1085907E (pt) 2004-08-31

Similar Documents

Publication Publication Date Title
AU758989B2 (en) Cosolvent formulations
HUP0002117A2 (hu) Érzéstelenítő vegyület átlátszó, injektálható összetételben
US6342530B1 (en) Composition and method for parenteral administration of ibuprofen d,l- or l-lysine salt
KR100608176B1 (ko) 프로스타글란딘 및 벤질 알코올을 포함하는 용액제
WO2009047634A2 (en) Aqueous formulations of acetaminophen for injection
CA2615053C (en) Pharmaceutical formulations of endo-n-(9-methyl-9-azabicyclo[3.3.1]non-3-yl)-1-methyl-1h-indazole-3-carboxamide hydrochloride
JPS6245524A (ja) ナトリウムフエニトイン水性製剤
EP2571498A1 (en) Pharmaceutical aqueous compositions comprising lipoic acid as an antioxidant
RU2248199C1 (ru) Глазные капли и способ их получения
MXPA00012423A (en) Solution comprising prostaglandins and benzyl alcohol
HK1036413B (en) Solution comprising prostaglandins and benzyl alcohol
CN120018849A (zh) 用于眼科疾病的萘衍生物基治疗药物
WO2024171210A1 (en) Sterile parenteral formulations of flucytosine
JPH10287569A (ja) アシクロビル又はその塩の輸液型キット注射剤
EE05864B1 (et) 3-hüdroksütsüklopentoonitsüklit sisaldava ühendi kompositsioon ja meetod selle stabiliseerimiseks
CS238503B1 (cs) Způsob přípravy a stabilizace infúzních a injekčních roztoků hydrogenuhličitanu sodného
SI9300029A (en) Lecithin-containing solutions with levemopamil

Legal Events

Date Code Title Description
PA0105 International application

Patent event date: 20001216

Patent event code: PA01051R01D

Comment text: International Patent Application

PG1501 Laying open of application
A201 Request for examination
PA0201 Request for examination

Patent event code: PA02012R01D

Patent event date: 20040211

Comment text: Request for Examination of Application

E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

Comment text: Notification of reason for refusal

Patent event date: 20051025

Patent event code: PE09021S01D

E701 Decision to grant or registration of patent right
PE0701 Decision of registration

Patent event code: PE07011S01D

Comment text: Decision to Grant Registration

Patent event date: 20060502

GRNT Written decision to grant
PR0701 Registration of establishment

Comment text: Registration of Establishment

Patent event date: 20060726

Patent event code: PR07011E01D

PR1002 Payment of registration fee

Payment date: 20060727

End annual number: 3

Start annual number: 1

PG1601 Publication of registration
PR1001 Payment of annual fee

Payment date: 20090630

Start annual number: 4

End annual number: 4

PR1001 Payment of annual fee

Payment date: 20100630

Start annual number: 5

End annual number: 5

PR1001 Payment of annual fee

Payment date: 20110629

Start annual number: 6

End annual number: 6

PR1001 Payment of annual fee

Payment date: 20120628

Start annual number: 7

End annual number: 7

FPAY Annual fee payment

Payment date: 20130628

Year of fee payment: 8

PR1001 Payment of annual fee

Payment date: 20130628

Start annual number: 8

End annual number: 8

FPAY Annual fee payment

Payment date: 20140627

Year of fee payment: 9

PR1001 Payment of annual fee

Payment date: 20140627

Start annual number: 9

End annual number: 9

PR1001 Payment of annual fee

Payment date: 20150630

Start annual number: 10

End annual number: 10

FPAY Annual fee payment

Payment date: 20160629

Year of fee payment: 11

PR1001 Payment of annual fee

Payment date: 20160629

Start annual number: 11

End annual number: 11

FPAY Annual fee payment

Payment date: 20170629

Year of fee payment: 12

PR1001 Payment of annual fee

Payment date: 20170629

Start annual number: 12

End annual number: 12

FPAY Annual fee payment

Payment date: 20180628

Year of fee payment: 13

PR1001 Payment of annual fee

Payment date: 20180628

Start annual number: 13

End annual number: 13

EXPY Expiration of term
PC1801 Expiration of term

Termination date: 20191208

Termination category: Expiration of duration